Viewing Study NCT02398058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2026-01-28 @ 4:04 PM
Study NCT ID: NCT02398058
Status: COMPLETED
Last Update Posted: 2021-04-14
First Post: 2015-01-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)
Sponsor: Italian Sarcoma Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Soft Tissue Sarcoma View
None Bone Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None trabectedin View
None olaparib View
None sarcoma View
None bone tumor View